Abstract:Circulation Research, Ahead of Print. Background:Increasing evidence suggests that long noncoding RNAs play significant roles in vascular biology and disease development. One such long noncoding RNA,PSMB8-AS1, has been implicated in the development of tumors. Nevertheless, the precise role ofPSMB8-AS1in cardiovascular diseases, particularly atherosclerosis, has not been thoroughly elucidated. Thus, the primary aim of this investigation is to assess the influence ofPSMB8-AS1on vascular inflammation and the initiation of atherosclerosis.Methods:We generatedPSMB8-AS1knockin andApoe(Apolipoprotein E) knockout mice (Apoe−/−PSMB8-AS1KI) and globalApoeand proteasome subunit-β type-9 (Psmb9) double knockout mice (Apoe−/−Psmb9−/−). To explore the roles ofPSMB8-AS1andPsmb9in atherosclerosis, we fed the mice with a Western diet for 12 weeks.Results:Long noncoding RNAPSMB8-AS1is significantly elevated in human atherosclerotic plaques. Strikingly,Apoe−/−PSMB8-AS1KImice exhibited increased atherosclerosis development, plaque vulnerability, and vascular inflammation compared withApoe−/−mice. Moreover, the levels of VCAM1 (vascular adhesion molecule 1) and ICAM1 (intracellular adhesion molecule 1) were significantly upregulated in atherosclerotic lesions and serum ofApoe−/−PSMB8-AS1KImice. Consistently, in vitro gain- and loss-of-function studies demonstrated thatPSMB8-AS1induced monocyte/macrophage adhesion to endothelial cells and increased VCAM1 and ICAM1 levels in a PSMB9-dependent manner. Mechanistic studies revealed thatPSMB8-AS1inducedPSMB9transcription by recruiting the transcription factor NONO (non-POU domain-containing octamer-binding protein) and binding to thePSMB9promoter. PSMB9 (proteasome subunit-β type-9) elevated VCAM1 and ICAM1 expression via the upregulation of ZEB1 (zinc finger E-box-binding homeobox 1).Psmb9deficiency decreased atherosclerotic lesion size, plaque vulnerability, and vascular inflammation inApoe−/−mice in vivo. Importantly, endothelial overexpression ofPSMB8-AS1-increased atherosclerosis and vascular inflammation were attenuated byPsmb9knockout.Conclusions:PSMB8-AS1promotes vascular inflammation and atherosclerosis via the NONO/PSMB9/ZEB1 axis. Our findings support the development of new long noncoding RNA–based strategies to counteract atherosclerotic cardiovascular disease.

The Role of the LncRNA-FA2H-2-MLKL Pathway in Atherosclerosis by Regulation of Autophagy Flux and Inflammation Through Mtor-Dependent Signaling

LncRNA-modulated autophagy in plaque cells: a new paradigm of gene regulation in atherosclerosis?

Novel long noncoding lncARF mediated hyperhomocysteinemia-induced atherosclerosis via autophagy inhibition in foam cells

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis

LncRNA ZFAS1 Confers Inflammatory Responses and Reduces Cholesterol Efflux in Atherosclerosis Through Regulating Mir-654-3p-adam10/ RAB22A Axis

Long Noncoding RNA FLRL2 Alleviated Nonalcoholic Fatty Liver Disease Through Arntl‐Sirt1 Pathway

LncRNA HOTAIR Inhibits miR-19a-3p to Alleviate Foam Cell Formation and Inflammatory Response in Atherosclerosis

lncRNA CASC7 regulates pathological progression of ox-LDL-stimulated atherosclerotic cell models via sponging miR-21 and regulating PI3K/Akt and TLR4/NF-κB signaling pathways

Regulatory Roles of Related Long Non-coding RNAs in the Process of Atherosclerosis

A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus

Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signaling pathway

circRNA/lncRNA-miRNA-mRNA Network in Oxidized, Low-Density, Lipoprotein-Induced Foam Cells

KPNA2 Silencing, Regulated by E3 Ubiquitin Ligase FBXW7, Alleviates Endothelial Dysfunction and Inflammation Through Inhibiting the Nuclear Translocation of p65 and IRF3: A Possible Therapeutic Approach for Atherosclerosis

LncRNA PSMB8-AS1 Instigates Vascular Inflammation to Aggravate Atherosclerosis

LncRNA MALAT1 Enhances ox-LDL-Induced Autophagy through the SIRT1/MAPK/NF-κB Pathway in Macrophages

Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5

LncRNA AC096664.3/PPAR‐γ/ABCG1‐dependent Signal Transduction Pathway Contributes to the Regulation of Cholesterol Homeostasis

Abstract Tu014: Endoplasmic reticulum stress exacerbates atherosclerosis via microRNA-181a by inhibiting mitophagy

Microarray profiling analysis and validation of novel long noncoding RNAs and mRNAs as potential biomarkers and their functions in atherosclerosis

LncRNA: An Important Regulator of Atherosclerosis